Download PDF
1 / Pages

Other users also viewed these articles

THE NEW TOBACCO COMPANIES OFFENSIVE: THE NICOTINE POUCHES José Ignacio de Granda-Orive; Carlos A. Jiménez-Ruiz; Mina Gaga;
10.1016/j.arbres.2024.10.017
Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients Marcela Valverde-Monge; Patricia Sánchez-Carrasco; Diana Betancor; Blanca Barroso; José Manuel Rodrigo-Muñoz; Ignacio Mahillo-Fernández; Ebymar Arismendi; Irina Bobolea; Blanca Cárdaba; María Jesús Cruz; Victoria Del Pozo; Javier Domínguez-Ortega; Francisco Javier González-Barcala; José María Olaguibel; Juan Alberto Luna-Porta; Carlos Martínez-Rivera; Joaquim Mullol; Xavier Muñoz; Lorena Peleteiro-Pedraza; Cesar Picado Valles; Vicente Plaza; Santiago Quirce; Manuel Jorge Rial; Lorena Soto-Retes; Antonio Valero; Joaquín Sastre;
Arch Bronconeumol. 2024;60:23-32
The Role of Inflammatory Phenotype in Patients With Exacerbation-prone Asthma and Ongoing Therapy María Florencia Pilia; María Jesús Cruz; Donghai Ma; Christian Romero-Mesones; David Espejo; Amaia Ojanguren; María Antonia Ramon; Xavier Muñoz; Iñigo Ojanguren;
Arch Bronconeumol. 2023;59:736-42